We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 10.8%
3 Consumer Discretionary 9.19%
4 Financials 8.28%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLAB icon
2276
Photronics
PLAB
$1.89B
$102K ﹤0.01%
5,238
-7,995
-60% -$140K
PPC icon
2277
Pilgrim's Pride
PPC
$6.31B
$102K ﹤0.01%
3,280
-899
-22% -$26.4K
SITC icon
2278
SITE Centers
SITC
$158M
$102K ﹤0.01%
9,667
+7,892
+445% +$93.1K
SSTI icon
2279
SoundThinking
SSTI
$105M
$102K ﹤0.01%
3,796
+3,067
+421% +$85.9K
SUM
2280
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$102K ﹤0.01%
4,472
+3,456
+340% +$91.8K
CMRA
2281
DELISTED
Comera Life Sciences Holdings, Inc. Common Stock
CMRA
$102K ﹤0.01%
+38,454
New +$127K
AGI icon
2282
Alamos Gold
AGI
$13.9B
$101K ﹤0.01%
14,403
-18,178
-56% -$141K
ATRA icon
2283
Atara Biotherapeutics
ATRA
$77.6M
$101K ﹤0.01%
519
-282
-35% -$46K
CBL
2284
CBL Properties
CBL
$1.72B
$101K ﹤0.01%
+4,312
New +$120K
ESGR
2285
DELISTED
Enstar Group
ESGR
$101K ﹤0.01%
470
-86
-15% -$20K
FN icon
2286
Fabrinet
FN
$18.9B
$101K ﹤0.01%
1,252
+858
+218% +$77.2K
HOPE icon
2287
Hope Bancorp
HOPE
$1.79B
$101K ﹤0.01%
7,359
+1,437
+24% +$21K
LGLV icon
2288
State Street SPDR US Large Cap Low Volatility Index ETF
LGLV
$1.23B
$101K ﹤0.01%
775
-2,802
-78% -$384K
TMDV icon
2289
ProShares Russell US Dividend Growers ETF
TMDV
$4.83M
$101K ﹤0.01%
2,292
-5,097
-69% -$237K
CMBT
2290
CMB.TECH NV
CMBT
$4.67B
$101K ﹤0.01%
8,463
+5,742
+211% +$69.1K
ABB
2291
DELISTED
ABB Ltd
ABB
$101K ﹤0.01%
3,796
+563
+17% +$16.7K
ALRM icon
2292
Alarm.com
ALRM
$2.79B
$100K ﹤0.01%
1,619
-2,168
-57% -$133K
CVGW
2293
DELISTED
Calavo Growers
CVGW
$100K ﹤0.01%
2,385
-2,840
-54% -$103K
DWAS icon
2294
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$444M
$100K ﹤0.01%
1,478
-551
-27% -$43.2K
GEVO icon
2295
Gevo
GEVO
$382M
$100K ﹤0.01%
42,464
+36,443
+605% +$133K
KROS icon
2296
Keros Therapeutics
KROS
$212M
$100K ﹤0.01%
3,632
+3,255
+863% +$143K
OTTR icon
2297
Otter Tail
OTTR
$3.88B
$100K ﹤0.01%
1,488
+940
+172% +$59.8K
RCMT icon
2298
RCM Technologies
RCMT
$205M
$100K ﹤0.01%
4,927
+3,099
+170% +$58.6K
YORW icon
2299
York Water
YORW
$518M
$100K ﹤0.01%
2,450
-4,010
-62% -$162K
HPK icon
2300
HighPeak Energy
HPK
$1B
$99K ﹤0.01%
3,863
+3,450
+835% +$100K

Similar funds

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.